Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Important milestones in acute leukemia in 2013.

Best practice & research. Clinical haematology - 1 Sept 2013

Rowe Jacob M

Abstract excerpt

This year marked the occurrence of several important milestones in the treatment of acute leukemias. First, the standard 7 + 3 protocol for acute myeloid leukemia (AML) was developed 40 years ago, and with some adaptations, has stood the test of time. Second, the 1 millionth hematopoietic cell transplant was recorded this year. Stem cell transplant, the first reported by Dr E. Donnall Thomas in 1957, had been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Cytarabine
Share to Daunorubicin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hematopoietic Stem Cell Transplantation

Share to History, 20th Century

Share to History, 21st Century

Share to Remission Induction

Share to Survival Analysis

Source

Identifiers

PMID: 24309524
DOI: 10.1016/j.beha.2013.10.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Important milestones in acute leukemia in 2013.PMID 24309524Read ↗

Novel therapeutic strategies for AML in 2012.Semantic proximity Read ↗

To transplant or not to transplant for adult acute myeloid leukemia: an ever-evolving decision.Semantic proximity Read ↗

New agents for acute myeloid leukemia: is it time for targeted therapies?Semantic proximity Read ↗

Advances in acute myeloid leukemia differentiation therapy: A critical reviewSemantic proximity Read ↗

Accelerated and Blast Phase Myeloproliferative Neoplasms.Semantic proximity Read ↗

A shadow in the treatment of acute leukemia: lineage switchSemantic proximity Read ↗

Predictive and Prognostic Markers in Adults With Acute Myeloid Leukemia: A Single-Institution Experience.Semantic proximity Read ↗

Mixed phenotype acute leukemia: outcomes with allogeneic stem cell transplantation. A retrospective study from the Acute Leukemia Working Party of the EBMT.Semantic proximity Read ↗

Evolution of Allogeneic Stem Cell Transplantation: Main Focus on AMLSemantic proximity Read ↗

Fludarabine and cytarabine versus high-dose cytarabine in consolidation treatment of t(8; 21) acute myeloid leukemia: A prospective, randomized study.Semantic proximity Read ↗

Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer CenterSemantic proximity Read ↗

Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.